Investigating new molecules that control how platelets activate
Novel signaling molecules regulating platelet activation
This study is looking at how platelets, the tiny cells that help your blood clot, behave in different diseases like cancer and heart issues, and it aims to find new ways to help improve treatments for people with these conditions, especially as they age or if they have diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11113877 on NIH RePORTER |
What this research studies
This research focuses on understanding how platelets, which are crucial for blood clotting, respond to their environment and activate in various disease states such as cancer and atherosclerosis. The team aims to identify new signaling molecules that regulate platelet activation and explore how these processes change with age and conditions like diabetes. By studying the intricate signaling networks within platelets, the research seeks to uncover potential therapeutic targets that could improve patient outcomes in diseases associated with abnormal platelet function.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with atherosclerotic cardiovascular disease, diabetes, or other conditions that affect platelet function.
Not a fit: Patients who do not have any platelet-related disorders or cardiovascular diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent thrombotic events in patients with cardiovascular diseases and other conditions.
How similar studies have performed: Previous research has shown promise in understanding platelet signaling pathways, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kunapuli, Satya P. — Temple Univ of the Commonwealth
- Study coordinator: Kunapuli, Satya P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.